BEIJING--(BUSINESS WIRE)--Pharmaron released today an updated summary of its GLP toxicology track record. Pharmaron has operated GLP toxicology facilities in Beijing, China since 2006, and boasts the broadest and most diverse toxicology track record for a CRO with western standards in China. Pharmaron partners are predominantly US biotech and pharmaceutical companies who intend to file IND applications in the US, Europe and Asia.
